Literature DB >> 23445350

Healthcare utilization and health-related quality of life of adult survivors of preterm birth complicated by bronchopulmonary dysplasia.

Stéphane Beaudoin1, Geneviève M Tremblay, Dan Croitoru, Andrea Benedetti, Jennifer S Landry.   

Abstract

AIM: This study aims to characterize the impact of preterm birth, respiratory distress syndrome and bronchopulmonary dysplasia on quality of life and healthcare utilization in adulthood.
METHODS: A mail survey on quality of life and respiratory health was sent to a list of potential subjects identified using the databases of the Régie de l'asssurance maladie du Québec. Four groups of adults born between 1987 and 1993 were compared: (i) preterm with bronchopulmonary dysplasia, (ii) preterm with respiratory distress syndrome, (iii) preterm without respiratory complications and (iv) term controls. As a complement, data from the governmental healthcare administrative databases were extracted for responders.
RESULTS: Although the groups differed in their use of healthcare services and prescription drugs, no clinically significant difference was observed for Saint George's Respiratory Questionnaire (SGRQ), SF-36v2 and Medical Research Council (MRC) Dyspnea Scale scores. However, compared to term subjects, bronchopulmonary dysplasia subjects were less likely to access higher education and more likely to be either invalid or unemployed.
CONCLUSION: Compared to term subjects, subjects with a history of prematurity and respiratory distress syndrome or bronchopulmonary dysplasia had similar health-related quality of life and respiratory symptoms despite greater use of healthcare services and prescription drugs. ©2013 The Author(s)/Acta Paediatrica ©2013 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2013        PMID: 23445350     DOI: 10.1111/apa.12217

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

Review 1.  Quality of life of individuals born preterm: a systematic review of assessment approaches.

Authors:  Martina Estevam Brom Vieira; Maria Beatriz Martins Linhares
Journal:  Qual Life Res       Date:  2016-03-19       Impact factor: 4.147

2.  Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.

Authors:  Rita M Ryan; Roberta L Keller; Brenda B Poindexter; Carl T D'Angio; Pamela A Shaw; Scarlett L Bellamy; Paul E Moore; Christopher McPherson; James M Greenberg
Journal:  J Pediatr       Date:  2019-03-08       Impact factor: 4.406

3.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

4.  Development and construct validation of a parent-proxy quality of life instrument in children with bronchopulmonary dysplasia aged 4-8 years old.

Authors:  Lysbert Meijer-Schaap; Anthony E J Dubois; Boudewijn J Kollen; Jet Tijmens-van der Hulst; Bertine M J Flokstra-de Blok; Elianne J L E Vrijlandt
Journal:  Qual Life Res       Date:  2018-10-22       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.